Login
$OFIX
$6.80 +$0.00 (0.0%) After hours

$OFIX SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G
16 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 SCHEDULE 13D/A
12 Nov 2026 Form 4: Juniper Investment Company, Llc, 10% owner and 2 others

Bought 675,000 shares ($5M) · Bought 14,803 shares ($104K)

09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

LEWISVILLE, Texas — November 9, 2026 — Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported financial results for the third quarter ended September 30, 2026, and revised its full-year 2026 net ...

04 Nov 2026 Form 4: Fisher Patrick, President, Global Limb Recon

Sold 150 shares ($1.36K)

05 Oct 2026 Form 4: Fisher Patrick, President, Global Limb Recon

Sold 150 shares ($1.42K)

23 Sep 2026 Form 4/A: Juniper Investment Company, Llc, 10% owner and 2 others

Bought 120,000 shares ($1.05M) · Bought 190,000 shares ($1.68M)

22 Sep 2026 Form 4: Juniper Investment Company, Llc, 10% owner and 2 others

Acquired 120,000 shares (Open Market Sale) ($1.05M) · Acquired 190,000 shares (Open Market Sale) ($1.68M)

03 Sep 2026 Form 4: Fisher Patrick, President, Global Limb Recon

Sold 150 shares ($1.41K)

01 Sep 2026 144
20 Aug 2026 Form 4: Fisher Patrick, President, Global Limb Recon

Sold 1,295 shares ($13.1K)

18 Aug 2026 Form 4: Juniper Investment Company, Llc, 10% owner and 2 others

Acquired 19,500 shares (Open Market Sale) ($202K) · Acquired 20,000 shares (Open Market Sale) ($200K)

14 Aug 2026 SCHEDULE 13G/A
05 Aug 2026 S-8
05 Aug 2026 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

LEWISVILLE, Texas — August 5, 2026 — Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more foc...

02 Jul 2026 8-K: Regulation FD Disclosure

On April 16, 2026, the U.S. Food and Drug Administration (“FDA”) issued a final order reclassifying non-invasive bone growth stimulators from Class III to Class II devices. Following that order, the Centers for Medicare & Medicaid Servic...

22 Jun 2026 Form 4: McPherron Aviva, Pres, Global Ops & Qual

Sold 3,670 shares ($34.4K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support